Fesilinient has not been studied in women after breast cancer. It may well do, but that studies yet to be done. I think from speaking to people, there have been some frustrations about perhaps lack of funding for something that affects so many women. There is more funding now, but you know what? Funding is medical research funding is tight. We're competing for the POT, for cancer, mental health, cardiovascular disease, stroke, neurological conditions. Money needs to be spent in research. Could I argue that we should be diverging it all away from blood disorders and blood cancers to menopause? No, but we need quality research.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode